HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting truncated RXRα for cancer therapy.

Abstract
Retinoid X receptor-alpha (RXRα), a unique member of the nuclear receptor superfamily, is a well-established drug target, representing one of the most important targets for pharmacologic interventions and therapeutic applications for cancer. However, how RXRα regulates cancer cell growth and how RXRα modulators suppress tumorigenesis are poorly understood. Altered expression and aberrant function of RXRα are implicated in the development of cancer. Previously, several studies had demonstrated the presence of N-terminally truncated RXRα (tRXRα) proteins resulted from limited proteolysis of RXRα in tumor cells. Recently, we discovered that overexpression of tRXRα can promote tumor growth by interacting with tumor necrosis factor-alpha-induced phosphoinositide 3-kinase and NF-κB signal transduction pathways. We also identified nonsteroidal anti-inflammatory drug Sulindac and analogs as effective inhibitors of tRXRα activities via a unique binding mechanism. This review discusses the emerging roles of tRXRα and modulators in the regulation of cancer cell survival and death as well as inflammation and our recent understanding of tRXRα regulation by targeting the alternate binding sites on its surface.
AuthorsXiaokun Zhang, Hu Zhou, Ying Su
JournalActa biochimica et biophysica Sinica (Acta Biochim Biophys Sin (Shanghai)) Vol. 48 Issue 1 Pg. 49-59 (Jan 2016) ISSN: 1745-7270 [Electronic] China
PMID26494413 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review)
Copyright© The Author 2015. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.
Chemical References
  • Ligands
  • NF-kappa B
  • Retinoid X Receptor alpha
  • Tumor Necrosis Factor-alpha
  • Phosphatidylinositol 3-Kinases
Topics
  • Animals
  • Apoptosis
  • Binding Sites
  • Cell Survival
  • Drug Discovery
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Inflammation
  • Ligands
  • Mice
  • NF-kappa B (metabolism)
  • Neoplasms (metabolism)
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Protein Binding
  • Protein Domains
  • Protein Multimerization
  • Retinoid X Receptor alpha (metabolism)
  • Signal Transduction (drug effects)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: